Go ahead for new treatment for Black Bone Disease
A new drug to treat the ultra-rare genetic disease alkaptonuria (AKU) has been given the go-ahead following research in Liverpool.
A new drug to treat the ultra-rare genetic disease alkaptonuria (AKU) has been given the go-ahead following research in Liverpool.
LJMU have secured prestigious funding to develop novel approaches to sustainable mining in the Philippines.
Liverpool John Moores University is set to train more people in diagnosing cancer thanks to a partnership with global optics firm Olympus.
Amid relief and joy, almost 100 of our own university colleagues collected their degrees this week. We spoke to a handful of them ...
Education, mental health, and social care downgraded or, in some cases, withdrawn altogether.
We caught up with the co-chairs of the current LJMU staff networks to find out what they have already achieved and what their plans are for 2022.
LJMU once again proved its commitment to supporting young people from disadvantaged backgrounds thanks to the Law Factor.
A mini-conference highlighting developments in decolonial approaches to teaching and research across the university featuring three sessions of talks and discussion on decolonising pedagogy, assessment and research methods, will take place in November.
Liverpool John Moores University has been chosen as the Consortium Secretariat of a new Going Global Partnership, funded by the British Council, with Malaysia. The new collaboration aims to promote strategic engagement and bilateral cooperation in higher education between partner institutions in both countries.
LJMU has collaborated with LCR to transfer £132,000 of unspent Apprenticeship Levy to Autism Initiatives, funding 44 new apprentice care workers for the charity.